1. Home
  2. PWM vs CPIX Comparison

PWM vs CPIX Comparison

Compare PWM & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PWM
  • CPIX
  • Stock Information
  • Founded
  • PWM 2018
  • CPIX 1999
  • Country
  • PWM Hong Kong
  • CPIX United States
  • Employees
  • PWM N/A
  • CPIX N/A
  • Industry
  • PWM
  • CPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PWM
  • CPIX Health Care
  • Exchange
  • PWM Nasdaq
  • CPIX Nasdaq
  • Market Cap
  • PWM 34.6M
  • CPIX 35.4M
  • IPO Year
  • PWM 2023
  • CPIX 2009
  • Fundamental
  • Price
  • PWM $1.45
  • CPIX $4.64
  • Analyst Decision
  • PWM
  • CPIX
  • Analyst Count
  • PWM 0
  • CPIX 0
  • Target Price
  • PWM N/A
  • CPIX N/A
  • AVG Volume (30 Days)
  • PWM 665.9K
  • CPIX 4.5M
  • Earning Date
  • PWM 02-14-2025
  • CPIX 03-04-2025
  • Dividend Yield
  • PWM N/A
  • CPIX N/A
  • EPS Growth
  • PWM N/A
  • CPIX N/A
  • EPS
  • PWM N/A
  • CPIX N/A
  • Revenue
  • PWM $348,528.00
  • CPIX $36,785,442.00
  • Revenue This Year
  • PWM N/A
  • CPIX N/A
  • Revenue Next Year
  • PWM N/A
  • CPIX N/A
  • P/E Ratio
  • PWM N/A
  • CPIX N/A
  • Revenue Growth
  • PWM N/A
  • CPIX N/A
  • 52 Week Low
  • PWM $0.67
  • CPIX $1.04
  • 52 Week High
  • PWM $2.70
  • CPIX $6.43
  • Technical
  • Relative Strength Index (RSI)
  • PWM 51.87
  • CPIX 83.81
  • Support Level
  • PWM $1.02
  • CPIX $2.08
  • Resistance Level
  • PWM $2.70
  • CPIX $6.43
  • Average True Range (ATR)
  • PWM 0.36
  • CPIX 0.53
  • MACD
  • PWM -0.02
  • CPIX 0.27
  • Stochastic Oscillator
  • PWM 29.38
  • CPIX 74.94

About PWM Prestige Wealth Inc.

Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: